Amphastar Pharmaceuticals (AMPH) Other Non Operating Income (2013 - 2026)

Amphastar Pharmaceuticals' Other Non Operating Income history runs 14 years deep, the most recent figure standing at $575000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 125.74% year-over-year to $575000.0; the TTM figure through Mar 2026 stood at $3.3 million (up 181.66% YoY), while the FY2025 annual figure was $522000.0, down 87.19% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $575000.0, down from $1.0 million in the prior quarter.
• The five-year high for Other Non Operating Income was $7.6 million in Q1 2022, with the low at -$5.5 million in Q4 2023.
• The 5-year median for Other Non Operating Income is $298000.0 (2024), against an average of $606588.2.
• The sharpest annual moves came in 2023 and 2024: Other Non Operating Income plunged 262.38% in 2023, then soared 1618.21% in 2024.
• Amphastar Pharmaceuticals' Other Non Operating Income stood at $3.4 million in 2022, then slumped by 262.38% to -$5.5 million in 2023, then jumped by 153.83% to $3.0 million in 2024, then sank by 65.64% to $1.0 million in 2025, then plunged by 43.29% to $575000.0 in 2026.
• Business Quant data shows AMPH's Other Non Operating Income at $575000.0 in Q1 2026, $1.0 million in Q4 2025, and $231000.0 in Q3 2025.